These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1136 related items for PubMed ID: 19365194

  • 1. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [Abstract] [Full Text] [Related]

  • 2. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Sezgin Akçay Bİ, Güney E, Bozkurt KT, Unlü C, Akçali G.
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):882-6. PubMed ID: 24180628
    [Abstract] [Full Text] [Related]

  • 3. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [Abstract] [Full Text] [Related]

  • 4. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.
    Kaback M, Scoper SV, Arzeno G, James JE, Hua SY, Salem C, Dickerson JE, Landry TA, Bergamini MV, Brinzolamide 1%/Timolol 0.5% Study Group.
    Ophthalmology; 2008 Oct; 115(10):1728-34, 1734.e1-2. PubMed ID: 18538406
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A, Paczka JA, Jiménez-Román J, Hartleben C.
    BMC Ophthalmol; 2014 Dec 19; 14():161. PubMed ID: 25527295
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM, Williams RD, Snyder E, Adamsons IA.
    Ophthalmology; 1999 Dec 19; 106(12 Suppl):17-24. PubMed ID: 10598693
    [Abstract] [Full Text] [Related]

  • 7. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
    Barnebey HS, Orengo-Nania S, Flowers BE, Samples J, Mallick S, Landry TA, Bergamini MV.
    Am J Ophthalmol; 2005 Jul 19; 140(1):1-7. PubMed ID: 15990081
    [Abstract] [Full Text] [Related]

  • 8. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.
    Ophthalmology; 2003 Mar 19; 110(3):615-24. PubMed ID: 12623832
    [Abstract] [Full Text] [Related]

  • 9. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K, Ito K, Okawa C, Sugimoto K, Matsunaga K, Uji Y.
    J Glaucoma; 2008 Mar 19; 17(3):233-7. PubMed ID: 18414111
    [Abstract] [Full Text] [Related]

  • 10. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M, Grigera DE, Barbosa WL, Jordao M, Susanna R.
    J Glaucoma; 2008 Dec 19; 17(8):674-9. PubMed ID: 19092465
    [Abstract] [Full Text] [Related]

  • 11. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L.
    Clin Ther; 2006 Apr 19; 28(4):552-9. PubMed ID: 16750466
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension.
    Suzuki ER, Franklin LM, da Silva LJ, Figueiredo CR, Netto JA, Batista WD.
    Curr Med Res Opin; 2006 Sep 19; 22(9):1799-805. PubMed ID: 16968583
    [Abstract] [Full Text] [Related]

  • 13. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group.
    Adamsons I, Clineschmidt C, Polis A, Taylor J, Shedden A, Laibovitz R.
    J Glaucoma; 1998 Aug 19; 7(4):253-60. PubMed ID: 9713783
    [Abstract] [Full Text] [Related]

  • 14. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE, Lai J.
    Ophthalmology; 2009 Sep 19; 116(9):1719-24. PubMed ID: 19592108
    [Abstract] [Full Text] [Related]

  • 15. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.
    Clin Ther; 2006 Mar 19; 28(3):332-9. PubMed ID: 16750448
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH, Feldman RM, Sheu WP, Fixed Combination Latanoprost/Timolol Study Group.
    Ophthalmology; 2004 Feb 19; 111(2):276-82. PubMed ID: 15019375
    [Abstract] [Full Text] [Related]

  • 17. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE, Friren B, International Brinzolamide Adjunctive Study Group.
    Am J Ophthalmol; 2001 Aug 19; 132(2):235-43. PubMed ID: 11476685
    [Abstract] [Full Text] [Related]

  • 18. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
    Liu JH, Medeiros FA, Slight JR, Weinreb RN.
    Ophthalmology; 2009 Mar 19; 116(3):449-54. PubMed ID: 19157559
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.
    Ozturk F, Ermis SS, Inan UU.
    Acta Ophthalmol Scand; 2007 Feb 19; 85(1):80-3. PubMed ID: 17244215
    [Abstract] [Full Text] [Related]

  • 20. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ, Szaflik J, Czechowicz-Janicka K, Kałuzny J, Orzałkiewicz A, Zaleska-Zmijewska A, Krajewska M, Stewart JA, Leech JN, Stewart WC.
    Klin Oczna; 2004 Feb 19; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.